Sullivan Brynne A, Fairchild Karen D
Neonatal/Perinatal Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
Division of Neonatology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Semin Fetal Neonatal Med. 2015 Aug;20(4):255-61. doi: 10.1016/j.siny.2015.03.006. Epub 2015 Mar 29.
Despite vigilant clinical assessment of infants in the neonatal intensive care unit (NICU), diagnosis of sepsis and necrotizing enterocolitis often does not occur until an infant has significant hemodynamic compromise. Predictive monitoring involves analysis of vital signs and other clinical data to identify infants at highest risk and to detect early-stage illness, leading to timelier treatment and improved outcomes. The first vital-sign predictive monitoring device developed for sepsis detection in babies in the NICU is the heart rate characteristics index (HeRO) monitor, which continuously analyzes the electrocardiogram signal for low heart rate variability and transient decelerations. Use of this monitor in very low birth weight infants (<1500 g) was shown in a large multicenter randomized clinical trial to significantly reduce mortality. The purpose of this review is (1) to summarize the physiologic changes in neonatal sepsis and progression to shock, (2) to review efforts toward risk stratification for sepsis shortly after birth based on demographic and physiologic scoring systems, (3) to describe development and implementation of heart rate characteristics monitoring and other important aspects of sepsis early warning systems, and (4) to provide an overview of current research analyzing multiple vital signs and other clinical variables in an attempt to develop even more effective predictive monitoring devices and systems.
尽管在新生儿重症监护病房(NICU)对婴儿进行了警惕的临床评估,但败血症和坏死性小肠结肠炎的诊断通常要到婴儿出现明显的血流动力学损害时才会发生。预测性监测涉及对生命体征和其他临床数据的分析,以识别风险最高的婴儿并检测早期疾病,从而实现更及时的治疗并改善预后。为在NICU中检测婴儿败血症而开发的首个生命体征预测监测设备是心率特征指数(HeRO)监测仪,它持续分析心电图信号以检测低心率变异性和短暂减速。在一项大型多中心随机临床试验中,极低出生体重婴儿(<1500 g)使用该监测仪可显著降低死亡率。本综述的目的是:(1)总结新生儿败血症的生理变化及进展为休克的过程;(2)回顾基于人口统计学和生理评分系统在出生后不久对败血症进行风险分层的努力;(3)描述心率特征监测的开发与实施以及败血症预警系统的其他重要方面;(4)概述当前分析多个生命体征和其他临床变量的研究,以尝试开发更有效的预测监测设备和系统。